Biomarker / companion diagnostics development

There is a critical need for surrogate pharmacodynamic biomarkers to evaluate the effects of new targeted therapeutics on molecular targets at all stages of the drug development process. Biomarkers also have potential use in the clinic in patient selection for treatment and monitoring of drug efficacy.

We offer an expert, fast and efficient service including:

• Antibody staining of tissue samples via immunohistochemistry
• Diagnostic analysis of immunohistochemical stained sections via semi-quantitative or quantitative scoring methods according to standardised protocols
• Preparation of full report spreadsheets tailored to customer needs and deadlines and meeting regulatory requirements

Diagnostic analysis is carried out by fully qualified, board certified and currently practicing human diagnostic pathologists with many years’ experience in human diagnostic pathology and assessment of antibody staining via immunohistochemistry